Practice guidelines for the early detection of cervical cancer in Korea: Korean Society of Gynecologic Oncology and the Korean Society for Cytopathology 2012 edition

Abstract

The consensus guideline development committee of Korean Society of Gynecologic Oncology was reconvened in March 2012. The committee consisted of 36 experts representing 12 university hospitals and professional organizations. The objective of this committee was to develop standardized guidelines for cervical cancer screening tests for Korean women and to distribute these guidelines to every clinician, eventually improving the quality of medical care. Since the establishment of the consensus guideline development committee, evidence-based guidelines have either been developed de novo considering specific Korean situations or by adaptation of preexisting consensus guidelines from other countries. Recommendations for cervical cancer screening tests, management of atypical squamous and glandular cells, and management of low-grade and high-grade squamous intraepithelial lesions were developed. Additionally, recommendations for human papillomavirus DNA testing and recommendations for adolescent and pregnant women with abnormal cervical screening test results were also included.

Management of atypical squamous cells of undetermined significance or low‐grade squamous intraepithelial lesions of the uterine cervix with human papilloma virus infection among young women aged less than 25 years

“…Thus, it may be reasonable to consider the risk of accompanying CIN2 lesions in the management of young women with ASCUS or LSIL. 5,7 On the other hand, we also assessed the incidence of CIN3 according to age groups among HPV-positive women with ASCUS or LSIL. Moreover, in nations where the medical cost of colposcopic examination is low despite high quality control and accuracy, such as Korea, colposcopy for management of such patients might be beneficial.…”

“…5 Those guidelines recommend repeat cytology 12 months after findings of atypical squamous cells of undetermined significance (ASCUS) with HPV-positive results or low-grade squamous intraepithelial lesions (LSIL) regardless of the results of an HPV test in women aged 21-24 years, whereas immediate colposcopy is recommended for women in other age groups with the same results. 7 They recommend that sexually active women should begin getting Pap tests at the age of 20, and can discontinue them at age 70 if three or more consecutive tests are negative over the course of 10 years. [6][7][8][9][10] Guidelines for cervical cancer screening for Korean women were also released in 2012.…”

Analytical Performance of Sensitivity and Specificity for Rapid Multiplex High Risk Human Papillomavirus Detection Kit: HPV ViroCheck

“…It was recommended that specific HPV types in HR HPV-positive/cytology-negative women, and a positive test for HPV 16 or 18 should lead to colposcopy [7]. Especially, women for HPV 16 and/or 18 with ASC-US or LSIL cytology can be diagnosed directly to colposcopy and shown positive results [7,8].…”

Cervical Cancer Screening after Perimenopause: How Is Human Papillomavirus Test Performed?

“…Also, in women aged 30 to 65 years, co-testing using the combination of Pap cytology plus HPV DNA testing is the preferred cervical cancer screening method 15. In Korea, women aged more than 20 years, Pap test is recommended every year 26. After the role of HPV in cervical cancer was identified, the importance of HPV detection test as a screening test was emphasized.…”